Ignite Creation Date:
2025-12-24 @ 2:19 PM
Ignite Modification Date:
2026-01-17 @ 8:06 AM
Study NCT ID:
NCT02529995
Status:
COMPLETED
Last Update Posted:
2020-02-11
First Post:
2015-08-06
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase I, Study in Chinese NSCLC Patients
Sponsor:
AstraZeneca
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Carcinoma, Non-Small-Cell Lung With EGFR Mutation Positive | View |
Keywords: